LingVo.club
Level
Time of day may affect glioblastoma chemotherapy — Level B1 — purple and white plastic bottle

Time of day may affect glioblastoma chemotherapyCEFR B1

6 Dec 2025

Adapted from Washington U. in St. Louis, Futurity CC BY 4.0

Photo by Guido Hofmann, Unsplash

Level B1 – Intermediate
3 min
149 words

New research shows MGMT gene methylation and protein levels rise and fall across the day. MGMT repairs DNA damage caused by the chemotherapy drug temozolomide (TMZ), so these daily rhythms can change tumor sensitivity to treatment.

Researchers analysed five years of biopsy data from WashU Medicine colleagues Joshua Rubin, Will Leidig, and Omar Butt and found morning biopsies were more likely to be scored as methylated. Herzog suggested that biopsy timing could influence diagnosis and proposed a chronodiagnostic approach to improve treatment choice.

Graduate student Maria Gonzalez-Aponte measured MGMT levels in tumor cells and patient samples. Olivia Walch built a mathematical model that predicts when TMZ would be most effective. The team plans clinical tests of chronotherapy and will study drugs like dexamethasone to avoid treatment times that might promote tumor growth. The work was supported by NIH, NCI, Siteman Cancer Center, Barnes-Jewish Hospital, and WashU Medicine.

Difficult words

  • methylationa chemical change to DNA affecting gene activity
  • biopsyremoval of tissue to check for disease
    biopsies
  • chronotherapytreatment timed to the body's daily cycles
  • temozolomidea chemotherapy drug used to treat some tumors
  • modela simple representation to predict outcomes
  • sensitivityhow easily something responds to a treatment

Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.

Discussion questions

  • How could the time of day affect medical tests or treatment in your experience?
  • What are possible advantages or problems of giving cancer treatment at certain times of day?
  • If doctors used a chronodiagnostic approach, how might that change patient appointments in a hospital?

Related articles

Tofersen slows a rare form of ALS — Level B1
26 Dec 2025

Tofersen slows a rare form of ALS

A long-term study shows that tofersen, a drug for a rare genetic form of ALS, can slow disease progression and help some people improve. The trial followed participants for several years and recorded benefits and side effects.